Healthcare Sector

GILD

Market Tracker

$92.90
-4.01
(-4.14%)
5:20 pm
Next Earnings: (est.) 08/02/23 12:00 am
  • GILD (Selected)

    Gilead Sciences, Inc.

GILD Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

GILD Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

GILD Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

GILD Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

GILD Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

GILD Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
05/16/2025 PUT $95.00 6,515 +4,528 +227.88%
05/16/2025 PUT $93.00 3,594 +3,044 +553.45%
05/16/2025 PUT $90.00 6,866 +2,627 +61.97%
05/16/2025 CALL $108.00 1,636 +1,111 +211.62%
05/16/2025 CALL $100.00 1,701 +1,096 +181.16%
05/16/2025 PUT $91.00 1,951 +847 +76.72%
01/16/2026 PUT $67.50 2,393 -10 -0.42%
05/23/2025 CALL $105.00 42 -11 -20.75%
05/16/2025 PUT $110.00 317 -19 -5.65%
06/20/2025 PUT $82.50 1,819 -42 -2.26%
05/16/2025 PUT $105.00 1,525 -69 -4.33%
05/16/2025 CALL $70.00 201 -100 -33.22%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

GILD Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.05% 38.12M 2.91B
Income Fund of America Inc 2.70% 33.74M 2.58B
Vanguard 500 Index Fund 2.32% 28.99M 2.21B
Dodge & Cox Stock Fund 2.02% 25.19M 1.92B
Washington Mutual Investors Fund 1.57% 19.64M 1.5B
American Balanced Fund 1.37% 17.14M 1.31B
American Mutual Fund Inc 1.33% 16.67M 1.27B
Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF 1.31% 16.4M 1.25B
Fidelity 500 Index Fund 1.10% 13.75M 1.05B
SPDR S&P 500 ETF Trust 1.08% 13.5M 1.03B

GILD News

  • Merus annonce ses résultats financiers pour le premier trimestre 2025 et fait le point sur ses activités

    05/09 10:46 am

    GlobeNewswire Inc.

    Read more
  • Nurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs

    04/28 04:00 pm

    GlobeNewswire Inc.

    Read more
  • Gilead Cancer Drug Combined With Merck's Drug Effective In Difficult To Treat Type Of Breast Cancer

    04/21 02:49 pm

    Benzinga

    Read more
  • 2 High-Yielding ETFs Retirees Can Safely Build Their Portfolios Around

    04/17 05:45 am

    The Motley Fool

    Read more
  • 2 Top Dividend Stocks That Could Set You Up for Life

    04/09 07:00 am

    The Motley Fool

    Read more
  • Is Vertex Pharmaceuticals Stock a Buy?

    04/08 09:45 am

    The Motley Fool

    Read more
  • Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - Precision Medicine and Early Relapse Detection Drive MRD Testing Demand Worldwide

    04/08 04:48 am

    GlobeNewswire Inc.

    Read more
  • 3 Stocks Leading Healthcare’s Comeback as Wall Street Turns Defensive

    04/02 12:14 pm

    Investing.com

    Read more
  • Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed

    03/21 12:31 pm

    Benzinga

    Read more
  • Bispecific Antibody Market Opportunity, Drug Dosage, Patent, Price, Sales & Clinical Trials Insight 2030: New Report Highlights 600+ Bispecific Antibodies in Clinical Trials Worldwide

    03/12 08:48 am

    GlobeNewswire Inc.

    Read more
  • The Top Nasdaq-100 Stock in 2025 Has Nothing to Do With Artificial Intelligence (AI)

    03/11 04:20 am

    The Motley Fool

    Read more
  • Non-Small Cell Lung Cancer Market Set for Significant Growth Across the 7MM During the Study Period (2025-2034) Due to the Rising Novel Therapeutic Options | DelveInsight

    02/26 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Questex’s Fierce Pharma Unveils the Conference Program for the Inaugural Fierce Pharma Engage, Over 100 Speakers Confirmed to Deliver Unparalleled Education

    02/24 11:00 am

    GlobeNewswire Inc.

    Read more
  • Why Gilead Sciences Stock Is Jumping Today

    02/12 01:21 pm

    The Motley Fool

    Read more
  • Gilead Sciences Beats Q4 EPS Forecast

    02/11 05:40 pm

    The Motley Fool

    Read more
  • 3 Fabulous Dividend Stocks to Buy in February

    02/09 03:30 pm

    The Motley Fool

    Read more
  • These 2 Dividend Stocks Are Absolute Bargains Right Now

    02/08 09:30 am

    The Motley Fool

    Read more
  • 3 Top AI-Powered Biotech Stocks to Buy in February

    02/06 10:45 am

    The Motley Fool

    Read more
  • Global Pharma & Biotech CRM Software Market To Surpass Valuation of US$ 20.0 Billion by 2033 | Astute Analytica

    01/17 04:30 am

    GlobeNewswire Inc.

    Read more
  • Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference

    01/09 03:12 pm

    Benzinga

    Read more
  • NUT Midline Carcinoma Treatment Market Research Report 2023-2024 & 2034: Market Forecast by Treatment, Route of Administration, and End-User Across 5 Regions and 17+ Countries

    01/09 11:53 am

    GlobeNewswire Inc.

    Read more
  • Galapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus

    01/08 03:07 pm

    Benzinga

    Read more
  • Galapagos wil aandeelhouderswaarde ontgrendelen met voornemen tot splitsing in twee beursgenoteerde entiteiten

    01/08 02:30 am

    GlobeNewswire Inc.

    Read more
  • Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities

    01/08 02:30 am

    GlobeNewswire Inc.

    Read more
  • Burkitt Lymphoma Global Clinical Trials Review 2024: Clinical Trials by Region, Country, Trial Status, Trial Phase, Sponsor Type and End Point Status

    12/23 01:44 pm

    GlobeNewswire Inc.

    Read more
  • Cancer Monoclonal Antibodies Market to Grow at a 18.4% CAGR through 2031 | SkyQuest Technology

    12/09 08:10 am

    Benzinga

    Read more
  • Coccidioidomycosis Drugs Market to Reach US$ 634.3 Million by 2034, Expanding at a CAGR of 4.9% | Fact.MR Report

    12/04 08:00 am

    GlobeNewswire Inc.

    Read more
  • Personalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 | SkyQuest Technology

    11/26 08:30 pm

    Benzinga

    Read more
  • Personalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 | SkyQuest Technology

    11/26 08:30 pm

    GlobeNewswire Inc.

    Read more
  • Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024

    11/17 11:30 am

    GlobeNewswire Inc.

    Read more
  • Gilead Unveils Long-Term Data From Seladelpar In Patients With Rare Liver Disease

    11/15 03:14 pm

    Benzinga

    Read more
  • 3 Spectacular High-Yield Dividend Stocks to Buy in November

    11/10 10:30 am

    The Motley Fool

    Read more
  • Merus annonce ses résultats financiers pour le troisième trimestre 2024 et fait le point sur ses activités

    11/02 06:18 am

    GlobeNewswire Inc.

    Read more
  • 3 Absurdly Cheap Stocks That Pay High Dividends

    10/24 08:15 am

    The Motley Fool

    Read more
  • Gilead Sciences/Merck's Investigational Once-Weekly HIV Combo Therapy Shows Sustained Virus Suppression To 48 Weeks

    10/21 12:28 pm

    Benzinga

    Read more
  • After Failed Confirmatory Trial, Gilead Withdraws US Accelerated Approval Of Trodelvy As Bladder Cancer treatment

    10/18 02:34 pm

    Benzinga

    Read more
  • Anti-retroviral Drugs Market to hit USD 42.5 billion by 2032, says Global Market Insights Inc.

    09/25 06:00 am

    GlobeNewswire Inc.

    Read more
  • 3 Dirt Cheap Stocks to Buy Right Now

    09/21 07:36 am

    The Motley Fool

    Read more
  • Got $200? 2 Healthcare Stocks to Buy and Hold Forever

    09/14 08:45 am

    The Motley Fool

    Read more
  • Why Gilead Sciences Stock Thrashed the Market Today

    09/12 06:11 pm

    The Motley Fool

    Read more
  • Gilead Unveils 'Remarkable Outcomes' From Late-Stage Lenacapavir Study Showing Promise In Preventing HIV Infections

    09/12 01:46 pm

    Benzinga

    Read more
  • Liver Fibrosis Market Is Expected to Reach USD 43.98 Billion By 2030

    09/02 04:15 pm

    GlobeNewswire Inc.

    Read more
  • Gene Therapy Market Size to Reach USD 54.39 Billion By 2032 with CAGR of 23.12%, Boosted by Rising Genetic Disorders and Advances in CRISPR Technology

    08/30 08:59 am

    GlobeNewswire Inc.

    Read more
  • Biologics Market Size to Surge to USD 855.8 Billion by 2031 with a 6.9% CAGR, Fueled by Advanced Targeting of Biological Pathways – Report by Transparency Market Research, Inc.

    08/27 05:30 pm

    GlobeNewswire Inc.

    Read more
  • UK Patient's Perspective on the Corporate Reputation of Pharma, 2023-2024

    08/20 11:52 am

    GlobeNewswire Inc.

    Read more
  • 3 Stocks Retirees Should Absolutely Love

    08/10 06:50 am

    The Motley Fool

    Read more
  • Biotechnology Market Size and Growth | USD 4.25 Trillion by 2033

    08/06 11:55 am

    GlobeNewswire Inc.

    Read more
  • Merus gibt die Finanzergebnisse für das zweite Quartal 2024 bekannt und informiert über den aktuellen Geschäftsverlauf

    08/03 12:36 pm

    GlobeNewswire Inc.

    Read more
  • 2 Unstoppable Dividend Stocks to Buy if There's a Stock Market Sell-Off

    08/03 06:45 am

    The Motley Fool

    Read more
  • ACTG Presents Data Analysis at AIDS 2024 Showing - GlobeNewswire

    07/23 04:31 am

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: